| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 519.2K | $12.39M | - | |
| CFO | 226.6K | $5.41M | - | |
| Other | 167.0K | $3.99M | - | |
| Other | 133.2K | $3.18M | - | |
| Other | 108.9K | $2.60M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Robert Gut62 | Director | Sale+OE10b5-1 | 25,613 | $24.62 | $630,483.17 | -44.2% | -22.2% | - | |
| Jan 9, 2026 | Jack Kaye52 | Director | Sale+OE10b5-1 | 6,390 | $27.28 | $174,319.20 | -23.8% | -35.6% | - | |
| Nov 6, 2025 | Robert Gut62 | Director | Sale+OE10b5-1 | 31,434 | $27.26 | $856,881.00 | -43.9% | -3.1% | - | |
| Nov 4, 2025 | Jack Kaye52 | Director | Sale+OE10b5-1 | 38,810 | $30.34 | $1,177,517.30 | -65.5% | -18.9% | - | |
| Sep 26, 2025 | Christian Klemt59 | Chief Financial Officer | Sale+OE10b5-1 | 18,000 | $52.51 | $945,120.00 | -7.6% | -54.3% | -29.6% | |
| Sep 24, 2025 | Matthew C Kapusta64 | CEO, Managing Director | Sale+OE10b5-1 | 226,316 | $41.46 | $9,382,472.66 | -25.8% | -49.1% | -19.3% | |
| Jun 27, 2025 | Walid Abi-Saab | Chief Medical Officer | Sell | 1,466 | $13.92 | $20,406.72 | -1.0% | +279.9% | +242.8% | |
| Jun 20, 2025 | David D. Meek46 | Director | Sell | 2,112 | $14.45 | $30,518.40 | -5.8% | +3.7% | +212.4% | |
| Jun 20, 2025 | Madhavan Balachandran51 | Director | Sell | 2,112 | $14.45 | $30,518.40 | -5.3% | +3.7% | +212.4% | |
| Jun 20, 2025 | Robert Gut62 | Director | Sell | 3,336 | $14.45 | $48,205.20 | -5.5% | +3.7% | +212.4% |